Jeffrey Gelwicks, PhD Eli Lilly and company

Jeffrey T. Gelwicks, Ph.D. is the Senior Director, Global Quality Laboratories for Eli Lilly & Company.  He has responsibility for supporting the QC laboratories at Lilly, including product commercialization, global laboratory informatics systems, analytical stewardship for Lilly products, anti-counterfeiting initiatives and investigations, and providing specialized analytical technologies.

A native of Maryland, Dr. Gelwicks received his B.S. in chemistry from Towson State University in 1984 and his Ph.D. in 1989 in biochemistry from Indiana University.  He joined Merck & Co., Inc. in Rahway, NJ in 1989 as a Senior Research Analyst responsible for method development, validation, and troubleshooting for the QC organization.  In 1992, he became the Quality Control Manager for the API manufacturing facility in Albany, Georgia and in 1993 was promoted to Director, Quality Operations for the manufacturing facility in Elkton, Virginia.  In 2002, Dr. Gelwicks joined Eli Lilly as Director, Global Quality Assurance Auditing, responsible for GMP auditing activities globally, and in May 2004, he was appointed to the position of Director, Quality for Tippecanoe Laboratories.  In January 2008, Dr. Gelwicks became Senior Director for global quality in Elanco, Lilly’s animal health unit.  His responsibilities included global quality management for research and development, in-house and contract manufacturing, product distribution, and global affiliates.  In August 2013, Dr. Gelwicks assumed his current role.